These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28055283)

  • 1. CRP velocity and short-term mortality in ST segment elevation myocardial infarction.
    Milwidsky A; Ziv-Baran T; Letourneau-Shesaf S; Keren G; Taieb P; Berliner S; Shacham Y
    Biomarkers; 2017; 22(3-4):383-386. PubMed ID: 28055283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Zahler D; Rozenfeld KL; Stein M; Milwidsky A; Berliner S; Banai S; Arbel Y; Shacham Y
    J Nephrol; 2019 Jun; 32(3):437-443. PubMed ID: 30706372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Reactive Protein Velocity and the Risk of New Onset Atrial Fibrillation among ST Elevation Myocardial Infarction Patients.
    Zahler D; Merdler I; Rozenfeld KL; Shenberg G; Milwidsky A; Berliner S; Banai S; Arbel Y; Shacham Y
    Isr Med Assoc J; 2021 Mar; 23(3):169-173. PubMed ID: 33734630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group.
    Yanishi K; Nakamura T; Nakanishi N; Yokota I; Zen K; Yamano T; Shiraishi H; Shirayama T; Shiraishi J; Sawada T; Kohno Y; Kitamura M; Furukawa K; Matoba S
    PLoS One; 2016; 11(11):e0166391. PubMed ID: 27835698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
    Adatia K; Farag MF; Gue YX; Srinivasan M; Gorog DA
    Thromb Haemost; 2019 Nov; 119(11):1785-1794. PubMed ID: 31437861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between C-reactive protein level and echocardiography assessed left ventricular function in first ST-segment elevation myocardial infarction patients who underwent primary coronary intervention.
    Shacham Y; Topilsky Y; Leshem-Rubinow E; Arbel Y; Ben Assa E; Keren G; Roth A; Steinvil A
    J Cardiol; 2014 Jun; 63(6):402-8. PubMed ID: 24299986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.
    Bas HA; Aksoy F; Icli A; Varol E; Dogan A; Erdogan D; Ersoy I; Arslan A; Ari H; Bas N; Sutcu R; Ozaydin M
    Scand J Clin Lab Invest; 2017 Apr; 77(2):77-82. PubMed ID: 27905214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.
    Orozović V; Rafajlovski S; Gligić B; Miailović Z; Obradović S; Ratković N; Djenić N; Baskot B
    Prilozi; 2007 Jul; 28(1):23-38. PubMed ID: 17921916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
    Kahlon TS; Barn K; Akram MM; Blankenship JC; Bower-Stout C; Carey DJ; Sun H; Tompkins Weber K; Skelding KA; Scott TD; Green SM; Berger PB
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):245-251. PubMed ID: 27142567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of time of admission on short- and long-term mortality in the Vienna STEMI registry.
    Tscharre M; Jäger B; Farhan S; Christ G; Schreiber W; Weidinger F; Stefenelli T; Delle-Karth G; Kaff A; Maurer G; Huber K;
    Int J Cardiol; 2017 Oct; 244():1-6. PubMed ID: 28784440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.
    Tillmanns J; Fraccarollo D; Galuppo P; Wollert KC; Bauersachs J
    Int J Cardiol; 2017 Apr; 232():155-159. PubMed ID: 28082091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between C-Reactive Protein Velocity and Left Ventricular Function in Patients with ST-Elevated Myocardial Infarction.
    Banai A; Levit D; Morgan S; Loewenstein I; Merdler I; Hochstadt A; Szekely Y; Topilsky Y; Banai S; Shacham Y
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction.
    Gheno G; Libardoni M; Zeppellini R; Cucchini F
    Cardiologia; 1999 Dec; 44(12):1023-8. PubMed ID: 10687251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.